Headlands Technologies LLC Agios Pharmaceuticals, Inc. Transaction History
Headlands Technologies LLC
- $920 Million
- Q2 2024
A detailed history of Headlands Technologies LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 11,450 shares of AGIO stock, worth $534,600. This represents 0.05% of its overall portfolio holdings.
Number of Shares
11,450Holding current value
$534,600% of portfolio
0.05%Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$264 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$257 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$227 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$181 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$130 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.56B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...